×
About 1,228 results

ALLMedicine™ Microscopic Polyangiitis Center

Research & Reviews  413 results

Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vascu...
https://doi.org/10.1016/j.amjoto.2022.103485
American Journal of Otolaryngology; Stavrakas M, Smith R et. al.

May 15th, 2022 - ANCA-associated vasculitides (AAV) represent a group of diagnoses, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA). Most commonly, they present initially wit...

Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065666
Clinical Rheumatology; Carranza-Enríquez F, Meade-Aguilar JA et. al.

May 5th, 2022 - Rituximab is a first-line therapy in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Among previous studies evaluating its efficacy, the Hispanic/Latino population has been underrepresented. This study aimed ...

Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific AN...
https://doi.org/10.1016/j.autrev.2022.103100
Autoimmunity Reviews; Walker BS, Peterson LK et. al.

Apr 23rd, 2022 - To determine the impact of myeloperoxidase (MPO) and proteinase 3 (PR3) antigen-specific immunoassays in the stratification of patients at-risk for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) at diagnosis. A Medline...

Response to: Correspondence on '2022 American College of Rheumatology/European Alliance...
https://doi.org/10.1136/annrheumdis-2022-222362
Annals of the Rheumatic Diseases; Grayson PC, Robson JC et. al.

Mar 24th, 2022 - Response to: Correspondence on '2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis' by Joanna C Robson et al and '2022 American College of Rheumatol...

Clinical Features of ANCA-Associated Vasculitis in African American Patients in the Uni...
https://doi.org/10.1097/RHU.0000000000001838
Journal of Clinical Rheumatology : Practical Reports on R... Palomino L, Gaffo A et. al.

Mar 24th, 2022 - The aim of this study was to compare the clinical features at presentation of ANCA-associated vasculitis (AAV) between African American (AA) and White patients. This is a chart review of cases between January 2003 and December 2018. African Americ...

see more →

Guidelines  2 results

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41983
Arthritis & Rheumatology (Hoboken, N.J.); Suppiah R, Robson JC et. al.

Feb 3rd, 2022 - To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items ...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/art.41773
Arthritis & Rheumatology (Hoboken, N.J.); Chung SA, Langford CA et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic...

see more →

Drugs  6 results see all →

Clinicaltrials.gov  13 results

Analgesic Effect of rTMS in Vasculitic Neuropathy
https://clinicaltrials.gov/ct2/show/NCT04720196

Mar 8th, 2022 - Vasculitic neuropathies (VN) are a group of disorders resulting from inflammation of predominantly small vessels with destruction of their walls and subsequent ischemic damage of peripheral nerves. Neural damage may or may not coexist with the dam...

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
https://clinicaltrials.gov/ct2/show/NCT03920722

Jan 11th, 2022 - Microscopic polyangiitis (MPA), is a small-sized vessel necrotizing vasculitis associated with anti-neutrophils cytoplasmic antibody (ANCA). Treatment of ANCA associated vasculitis (AAV) was previously based on glucocorticoids (GC) and cyclophosph...

Evolution of Neuropathies Associated With Necrotizing Vasculitis
https://clinicaltrials.gov/ct2/show/NCT05164822

Dec 21st, 2021 - Necrotizing Vasculitis are inflammatory diseases of the wall of vessels. Neurological damage of the peripheral nerve varies from 7% to 50% of cases depending on the type of Necrotizing Vasculitis. Peripheral neurological impairment is rarely life ...

Rituximab in Eosinophilic Granulomatosis With Polyangiitis
https://clinicaltrials.gov/ct2/show/NCT02807103

Apr 14th, 2021 - Systemic vasculitides are inflammatory diseases of blood vessels, among which anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are often severe with life-threatening manifestations or complications. AAV include granulomato...

Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
https://clinicaltrials.gov/ct2/show/NCT03290456

Nov 22nd, 2019 - Immunosuppressive therapy of granulomatosis with polyangiitis (GPA, Wegener's) and microscopic polyangiitis (MPA) has transformed the outcome from death to a strong likelihood of disease control and temporary remission. However, most patients have...

see more →

News  54 results

Plasma Exchange Works for ANCA-Associated Vasculitis
https://www.medscape.com/viewarticle/969671

Mar 8th, 2022 - NEW YORK (Reuters Health) - Plasma exchange can be an effective treatment for anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV), according to an updated systematic review and meta-analysis. Granulomatosis with polyangiitis and ...

FDA Approves Rituximab for Multiple Pediatric Cancers
https://www.medscape.com/viewarticle/964124

Dec 3rd, 2021 - The US Food and Drug Administration yesterday approved rituximab (Rituxan) in combination with chemotherapy for pediatric patients (age 6 months to <18 years) with previously untreated, advanced stage, CD20-positive diffuse large B-cell lymphoma (...

New ACR Guidelines Give Advice on Six Forms of Vasculitis
https://www.medscape.com/viewarticle/954873

Jul 15th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr Sharon Chung "It's not unu...

FDA Panel Narrowly Backs Avacopan Approval
https://www.medscape.com/viewarticle/950728

May 7th, 2021 - A panel of federal advisers on May 6 lent support to the ChemoCentryx bid for approval of avacopan for a rare and serious autoimmune condition. But they also flagged concerns about both the evidence supporting claims of a benefit for this experime...

Connection Between Where You Live and Vasculitis Risk?
https://www.medpagetoday.com/rheumatology/generalrheumatology/92194

Apr 21st, 2021 - Living in a rural area was associated with an increased rate of renal granulomatosis with polyangiitis (GPA), which is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a nationwide study in Scotland found. Compared wi...

see more →

Patient Education  3 results see all →